Trial Profile
Efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Nov 2020
Price :
$35
*
At a glance
- Drugs Artemether/lumefantrine (Primary) ; Artesunate/amodiaquine (Primary) ; Dihydroartemisinin/piperaquine (Primary)
- Indications Falciparum malaria
- Focus Therapeutic Use
- 09 Nov 2020 Status changed from not yet recruiting to completed as per results published in the Antimicrobial Agents and Chemotherapy
- 09 Nov 2020 Results published in the Antimicrobial Agents and Chemotherapy
- 13 Mar 2015 New trial record